| Question | Score |
|---|
| Cohort | Score | vs. Avg |
|---|
| Dimension | Cohort Score | Population Avg | Delta | Visual Comparison |
|---|
Meridian Pharma's Q1 2026 Sales Force Effectiveness audit reveals a sales force in transition — overall alignment has improved 4 points since the prior audit, yet critical gaps in execution readiness and strategic belief persist. The composite SFE Alignment Score of 68/100 places Meridian 2 points above the industry median of 66, but 10 points below top-quartile performers.
The Strategy-to-Field Gap Index of 34 — down 6 points from Q1 2025 — reflects meaningful progress in strategic communication following last year's national sales meeting redesign. However, field representatives continue to report a disconnect between stated brand priorities and the practical realities of their call environments, particularly in primary care-heavy territories.
Sample: 60 of 98 field representatives, stratified by region and tenure. Interviews conducted February 1 – March 10, 2026. Field observations: 48 ride-alongs across 4 regions.
The audit employed a mixed-methods approach combining structured quantitative surveys, semi-structured qualitative interviews, and field observation ride-alongs. Each respondent completed a 47-item validated survey instrument across the 7 SFE dimensions, followed by a 30–45 minute qualitative interview conducted by a Pinnacle Consulting field auditor.
Respondents were selected using stratified random sampling to ensure representation across four regions (Northeast, Southeast, Midwest, West), three tenure cohorts (0–2 years, 3–5 years, 6+ years), and two primary product assignments (Cardova, Nexelon). The 61% response rate (60/98) meets the pre-specified threshold of 60% for statistical validity.
Each dimension is scored on a 0–100 scale derived from normalized Likert responses and qualitative coding. The composite SFE Alignment Score is a weighted average across dimensions, with weights validated against commercial performance outcomes in Pinnacle Consulting's proprietary benchmark database of 142 pharmaceutical sales forces.
Strategy Awareness is the strongest-performing dimension and sits above the industry median of 68. Awareness is highest among 6+ year veterans (76) and West region (75). The primary gap exists among new representatives, where scores drop to 54 — 22 points below the veteran cohort.
The 11-point gap between Awareness (72) and Belief (61) is the audit's most consequential finding. Representatives can articulate the specialty-first strategy but express skepticism about its applicability in their call environments. Most pronounced in Midwest territories with high primary care physician density.
Leadership Communication declined 2 points since Q1 2025 despite the manager training initiative conducted in Q3 2025. The Southeast region (44) and bottom performance quintile (49) show the most acute deficits.
This dimension has remained below 50 for three consecutive audits. Beyond training materials, reps cite CRM data quality (61% dissatisfied), sample management complexity (54% report inefficiency), and formulary access variability as compounding barriers.
| Dimension | Q1 2025 | Q1 2026 | Change |
|---|